Preferential translation of p53 target genes

References

• Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science. 2013;339:1546–1558.
   PubMed Web of Science ®Google Scholar
• Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14:359–370.
   PubMed Web of Science ®Google Scholar
• Riley T, Sontag E, Chen P, et al. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008;9:402–412.
   PubMed Web of Science ®Google Scholar
• El-deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817–825.
   PubMed Web of Science ®Google Scholar
• Brugarolas J, Chandrasekaran C, Gordon JI, et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 1995;377:552–557.
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang P, Harper JW, et al. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995;82:675–684.
   PubMed Web of Science ®Google Scholar
• Haupt Y, Maya R, Kazaz A, et al. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299.
   PubMed Web of Science ®Google Scholar
• Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res. 2003;1:1001–1008.
   PubMed Web of Science ®Google Scholar
• Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 2008;134:451–460.
   PubMed Web of Science ®Google Scholar
• Parmigiani A, Nourbakhsh A, Ding B, et al. Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep. 2014;9:1281–1291.
   PubMed Web of Science ®Google Scholar
• Chantranupong L, Wolfson RL, Orozco JM, et al. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep. 2014;9:1–8.
   PubMed Web of Science ®Google Scholar
• Jefferies HB, Fumagalli S, Dennis PB, et al. Rapamycin suppresses 5ʹTOP mRNA translation through inhibition of p70s6k. EMBO J. 1997;16:3693–3704.
   PubMed Web of Science ®Google Scholar
• Hsieh AC, Liu Y, Edlind MP, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012;485:55–61.
   PubMed Web of Science ®Google Scholar
• Thoreen CC, Chantranupong L, Keys HR, et al. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 2012;485:109–113.
   PubMed Web of Science ®Google Scholar
• Loayza-Puch F, Drost J, Rooijers K, et al. p53 induces transcriptional and translational programs to suppress cell proliferation and growth. Genome Biol. 2013;14:R32.
   PubMed Web of Science ®Google Scholar
• Mosner J, Mummenbrauer T, Bauer C, et al. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 1995;14:4442–4449.
   PubMed Web of Science ®Google Scholar
• Tournillon AS, Lopez I, Malbert-Colas L, et al. p53 binds the mdmx mRNA and controls its translation. Oncogene. 2017;36:723–730.
   PubMed Web of Science ®Google Scholar
• Galy B, Creancier L, Zanibellato C, et al. Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene. 2001;20:1669–1677.
   PubMed Web of Science ®Google Scholar
• Ewen ME, Oliver CJ, Sluss HK, et al. p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. Genes Dev. 1995;9:204–217.
   PubMed Web of Science ®Google Scholar
• Landers JE, Cassel SL, George DL. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res. 1997;57:3562–3568.
   PubMed Web of Science ®Google Scholar
• Brown CY, Mize GJ, Pineda M, et al. Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene. 1999;18:5631–5637.
   PubMed Web of Science ®Google Scholar
• Andrysik Z, Galbraith MD, Guarnieri AL, et al. Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity. Genome Res. 2017;27:1645–1657.
   PubMed Web of Science ®Google Scholar
• Liang S, Bellato HM, Lorent J, et al. Polysome-profiling in small tissue samples. Nucleic Acids Res. 2018;46:e3.
   PubMed Web of Science ®Google Scholar
• Zaccara S, Tebaldi T, Pederiva C, et al. p53-directed translational control can shape and expand the universe of p53 target genes. Cell Death Differ. 2014;21:1522–1534.
   PubMed Web of Science ®Google Scholar
• Rizzotto D, Zaccara S, Rossi A, et al. Nutlin-induced apoptosis is specified by a translation program regulated by PCBP2 and DHX30. Cell Rep. 2020;30:4355–4369 e4356.
   PubMed Web of Science ®Google Scholar
• Marcel V, Nguyen Van Long F, Diaz JJ. 40 years of research put p53 in translation. Cancers (Basel). 2018;10:152.
   PubMed Web of Science ®Google Scholar
• Ingolia NT, Ghaemmaghami S, Newman JR, et al. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218–223.
   PubMed Web of Science ®Google Scholar
• Schott J, Reitter S, Lindner D, et al. Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density. Nat Methods. 2021;18:1068–1074.
   PubMed Web of Science ®Google Scholar
• Schott J, Reitter S, Philipp J, et al. Translational regulation of specific mRNAs controls feedback inhibition and survival during macrophage activation. PLoS Genet (Research Support, Non-U.S. Gov’t). 2014;10:e1004368.
   Google Scholar
• Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Research Support, U.S. Gov’t, P.H.S.). 1998;282:1497–1501.
   Google Scholar
• Wek RC. Role of eIF2alpha kinases in translational control and adaptation to cellular stress. Cold Spring Harb Perspect Biol. 2018;10:a032870.
   PubMed Web of Science ®Google Scholar
• Fischer M. Census and evaluation of p53 target genes. Oncogene. 2017;36:3943–3956.
   PubMed Web of Science ®Google Scholar
• Carra G, Lingua MF, Maffeo B, et al. P53 vs NF-kappaB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa. Cell Mol Life Sci. 2020;77:4449–4458.
   PubMed Web of Science ®Google Scholar
• Sur S, Pagliarini R, Bunz F, et al. A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53. Proc Natl Acad Sci U S A. 2009;106:3964–3969.
   PubMed Web of Science ®Google Scholar
• Eichelbaum K, Winter M, Berriel Diaz M, et al. Selective enrichment of newly synthesized proteins for quantitative secretome analysis. Nat Biotechnol. 2012;30:984–990.
   PubMed Web of Science ®Google Scholar
• Friedrich D, Friedel L, Finzel A, et al. Stochastic transcription in the p53-mediated response to DNA damage is modulated by burst frequency. Mol Syst Biol. 2019;15:e9068.
   PubMed Web of Science ®Google Scholar
• Velasco-Miguel S, Buckbinder L, Jean P, et al. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene. 1999;18:127–137.
   PubMed Web of Science ®Google Scholar
• Kim KM, Cho H, Kim YK. The upstream open reading frame of cyclin-dependent kinase inhibitor 1A mRNA negatively regulates translation of the downstream main open reading frame. Biochem Biophys Res Commun. 2012;424:469–475.
   PubMed Web of Science ®Google Scholar
• Collier AE, Spandau DF, Wek RC. Translational control of a human CDKN1A mRNA splice variant regulates the fate of UVB-irradiated human keratinocytes. Mol Biol Cell. 2018;29:29–41.
   PubMed Web of Science ®Google Scholar
• Galy B, Creancier L, Prado-Lourenco L, et al. p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene. 2001;20:4613–4620.
   PubMed Web of Science ®Google Scholar
• Riley KJ, Maher LJ 3rd. p53 RNA interactions: new clues in an old mystery. RNA. 2007;13:1825–1833.
   PubMed Web of Science ®Google Scholar
• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16:421–433.
   PubMed Web of Science ®Google Scholar
• Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer. 2012;12:613–626.
   PubMed Web of Science ®Google Scholar
• Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
   PubMed Web of Science ®Google Scholar
• Hughes CS, Foehr S, Garfield DA, et al. Ultrasensitive proteome analysis using paramagnetic bead technology. Mol Syst Biol. 2014;10:757.
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367–1372.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Orre LM, Zhou Tran Y, et al. DEqMS: a method for accurate variance estimation in differential protein expression analysis. Mol Cell Proteomics. 2020;19:1047–1057.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar